Evidence report library
Browse health and science claims by evidence strength.
Search deHype reports by topic, grade, study type and clinical relevance. Each card gives the practical verdict first, then links to the full source-chain review.
Explore by topic
Top public report topics, ranked by current archive coverage.
Cancer
A guide to interpreting news and research about cancer, with evidence checks on headlines,…
7 reports
Dementia
Evidence checks about dementia headlines, Alzheimer’s claims, supplements, biomarkers, and…
7 reports
Diet and nutrition
Diet and nutrition headlines often exaggerate the strength of evidence, particularly when …
2 reports
Heart health
Evidence checks about cardiovascular headlines, cholesterol, blood pressure, stroke, stati…
1 report
Longevity
Explore evidence and critical reviews relating to ageing, biological age markers, and anti…
1 report
Mental health
Evidence checks about depression, anxiety, stress, psychedelics, apps, lifestyle intervent…
1 report
Latest evidence reports
Concise archive cards help readers decide whether to open the full source-chain report.
Evidence check: Dementia: Joint pain supplement may speed progression
The evidence for glucosamine accelerating dementia is preliminary, indirect, and partly observational; findings require replication and do not justify clinical changes at this stage.
Early-stage only Observational human evidence Not clinically actionable
Evidence check: Your nose could detect Alzheimer’s years before symptoms begin
The research offers scientific insight into early immune changes and olfactory loss in Alzheimer’s, but the article’s diagnostic and therapeutic framing exceeds the current clinical evidence.
Over-framed Limited human evidence Clinically actionable
Evidence check: Why some brain cells are particularly vulnerable to multiple sclerosis
The Science News article closely reflects the findings of recent peer-reviewed research linking DNA repair deficits in CUX2 neurons to progression of MS, but the evidence is primarily from mouse models and comparative human tissue studies, not clinical trials or interventions. The clinical actionability for patients or providers is currently nil, while the potential for future targeting remains hypothetical.
Early-stage only Limited human evidence